Literature DB >> 7388360

Improvement of anaemia in haemodialysed patients after viral or toxic hepatic cytolysis.

P Simon, A Meyrier, T Tanquerel, K S Ang.   

Abstract

Thirty patients receiving haemodialysis, including two who had undergone bilateral nephrectomy, showed significant increases (p less than 0.001) in packed cell volume, haemoglobin concentration, and reticulocyte count during an episode of viral or toxic liver cytolysis. In 19 cases the episode lasted a mean of 5.0 +/- SD 2.9 months and was accompanied by improved haematological values for a mean of 12.0 +/- 6.0 weeks. Of the remaining patients, in whom the episode lasted a mean of 8.0 +/- 3.5 months (p less than 0.02), seven showed continued improvement a mean of 30.0 +/- 16.0 weeks after cytolysis. In eight patients in this group there was an apparent correlation between persistently increased haemoglobin concentrations and biopsy evidence of chronic hepatitis. The findings suggest that the reduction in anaemia resulted from enhanced red-cell production mediated by secretion of erythropoietin from regenerating liver cells. If confirmed this might have important implications for the treatment of anaemia in chronic renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7388360      PMCID: PMC1601090          DOI: 10.1136/bmj.280.6218.892

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Hepatitis and epidemic hepatitis associated antigen (E.H.A.A.) in a haemodialysis unit with observations on haemoglobin levels.

Authors:  J C Coleman; J B Eastwood; J R Curtis; R A Fox; M S Edwards
Journal:  Br J Urol       Date:  1972-04

2.  A possible mechanism for the erythrocytosis associated with hepatocellular carcinoma in man.

Authors:  A S Gordon; E D Zanjani; R Zalusky
Journal:  Blood       Date:  1970-02       Impact factor: 22.113

3.  Erythropoietin and hepatoma.

Authors:  P Cannon; D G Penington
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

4.  Absolute erythrocytosis in early infectious hepatitis.

Authors:  H Bank; J Passwell
Journal:  Med Chir Dig       Date:  1974

5.  Influence of serum hepatitis on haemoglobin level in patients on regular haemodialysis.

Authors:  A J Kolk-Vegter; E Bosch; A M van Leeuwen
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

6.  The liver as a source of extrarenal erythropoietin production.

Authors:  W Fried
Journal:  Blood       Date:  1972-11       Impact factor: 22.113

7.  Erythropoiesis in renal insufficiency and in anephric man.

Authors:  J P Naets; M Wittek; C Toussaint; J Van Geertruyden
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

8.  The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses.

Authors:  W Fried; O Jonasson; G Lang; F Schwartz
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

9.  Fetal and neonatal erythropoiesis.

Authors:  G Lucarelli; A Porcellini; C Carnevali; A Carmena; F Stohlman
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

10.  Testosterone therapy for anaemia in maintenance dialysis.

Authors:  S Shaldon; K M Koch; F Oppermann; W D Patyna; W Schoeppe
Journal:  Br Med J       Date:  1971-07-24
View more
  3 in total

1.  Effect of HCV infection on hematocrit and hemoglobin level in Egyptian hemodialysis patients.

Authors:  Alaa Abdel-Aziz Sabry; Khaled F El-Dahshan; Khaled M Mahmoud; Amr A El-Husseini
Journal:  Int Urol Nephrol       Date:  2007-11-02       Impact factor: 2.370

2.  Prevalence and related factors of the absence of anemia among Chinese chronic hemodialysis patients: a multicenter cross-sectional study.

Authors:  Qijun Wan; Yongcheng He; Wanfan Zhang; Qiang Wu; Zibo Xiong
Journal:  Int Urol Nephrol       Date:  2013-10-11       Impact factor: 2.370

3.  Polycythaemia following renal transplantation.

Authors:  H P Davis
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.